Warning
: your browser is no longer supported.
CLICK HERE
to review the supported browser list.
CLICK HERE
to download a PDF version of this report to read and/or print.
2026 Proxy Statement
Menu
Close
Select Document
✔
{hosting_shortdoctitlestripped}
✔
{doc1_shortdoctitlestripped}
✔
{doc2_shortdoctitlestripped}
✔
{doc3_shortdoctitlestripped}
✔
{doc4_shortdoctitlestripped}
✔
{doc5_shortdoctitlestripped}
✔
{doc6_shortdoctitlestripped}
✔
{doc7_shortdoctitlestripped}
✔
{doc8_shortdoctitlestripped}
✔
{doc9_shortdoctitlestripped}
✔
{doc10_shortdoctitlestripped}
✔
{doc11_shortdoctitlestripped}
✔
{doc12_shortdoctitlestripped}
✔
{doc13_shortdoctitlestripped}
✔
{doc14_shortdoctitlestripped}
✔
{doc15_shortdoctitlestripped}
2026 Proxy Statement
2026 Strategic Priorites
Table of Contents
A Letter from Pfizer's Chairman and Chief Executive Officer
A Message from Pfizer's Lead Independent Director
Notice of 2026 Annual Meeting and Proxy Statement
Our Business and Strategy
Item 1 - Election of Directors
Criteria for Board Membership
Selection of Candidates
Director Independence
Our 2026 Director Nominees
Governance
Overview
Governance Materials Available on Our Website
The Board's Leadership Structure
The Board's Role in Risk Oversight
The Board's Role in Succession Planning
Evaluation of Board Effectiveness
Board and Committee Information
Governance Committee Report
Regulatory and Compliance Committee Report
Investor Outreach
Public Policy Engagement and Political Participation
Pfizer Policies on Business Conduct
Other Governance Practices and Policies
Non-Employee Director Compensation
2025 Director Compensation Table
Securities Ownership
Beneficial Owners
Delinquent Section 16(a) Reports
Item 2 - Ratification of Selection of Independent Registered Public Accounting Firm
Audit and Non-Audit Fees
Audit Committee Report
Item 3 - Approval of the Pfizer Inc. 2019 Stock Plan
Overview
Share Reserve Information
Usage of Shares Authorized for Grant
Reasons for Seeking Shareholder Approval
Additional Information About the Amended Plan
Types of Awards
U.S. Tax Treatment of Options and Awards
Item 4 - 2026 Advisory Approval of Executive Compensation
2025 Advisory Vote on Executive Compensation
2025 Pay-for-Performance
2026 Advisory Vote on Executive Compensation
Compensation Committee Report
Executive Compensation
Compensation Discussion and Analysis
Executive Summary
SECTION 1 - Elements of Our Executive Compensation Program
SECTION 2 - How We Determine Executive Compensation
SECTION 3 - How We Evaluate Performance: 2025 Compensation Decisions
SECTION 4 - Benefit Programs
SECTION 5 - Other Compensation Programs and Policies
Compensation Tables
Financial Measures
Shareholder Proposal
Item 5 - Adopt an Independent Chair Policy
Annual Meeting, Annex 1, Corporate and Shareholder Information
Annual Meeting Information
Annual Meeting
Voting
Proxy Materials
Other Questions
Other Business
Submitting Proxy Proposals and Director Nominations for the 2027 Annual Meeting
Annex 1 - Pfizer Inc. 2019 Stock Plan
Corporate and Shareholder Information
Meet our Director Nominees
Help & Features
Download PDF
Downloads
Company Home
Share
Print
Clickable Index
Thumbnails
Accessibility Features
Help
Menu
Zoom In
Zoom Out
Zoom In
Help
Help
TOC
TOC
PDF
PDF
Home
Home
Home
Home
Home
Zoom Out
Home
Home
Home
Home
Print
Print
Print
Clickable Index
Clickable Index
Thumbnails
Thumbnails
Help
Help
Unpin Menu Bar
Pin Menu Bar
Go to previous page
Go to previous page
Go to previous page
Go to previous page
Go to next page
Go to next page
Go to next page
Page 56 of 134
Single Page View
Double Page View
...Previous
Continue...
WARNING: JavaScript is disabled.
CLICK HERE
for help.
Click here
for a list of supported browsers.
